The global alcohol-related liver disease treatment market is poised for significant growth in the coming years. Driven by factors such as a rising prevalence of alcohol abuse and an senior population, demand for effective treatments is skyrocketing. Primary players in the market are investing resources to develop innovative therapies and broaden t